Novel Anthraquinone Compounds Induce Cancer Cell Death through Paraptosis

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Cancer Research

Background:

• Apoptosis is a key mechanism for cancer chemotherapy, but some tumor cells resist this pathway.
• Exploring alternative cell death mechanisms like paraptosis is crucial for overcoming drug resistance.

Purpose of the Study:

• To design and synthesize novel anthraquinone compounds that induce paraptosis.
• To investigate the mechanism of action of these compounds, particularly compound 4a.
• To evaluate paraptosis as a potential therapeutic strategy for cancer.

Main Methods:

• Synthesis of novel anthraquinone derivatives.
• Assessment of compound-induced cell death, focusing on paraptosis markers.
• Exploration of molecular mechanisms, including endoplasmic reticulum (ER) stress and autophagy markers (LC3II/I ratio).

Main Results:

• Compound 4a was identified as the first small molecule to induce tumor cell death exclusively through paraptosis.
• Paraptosis induction by compound 4a did not involve phosphatidylserine translocation or cell cycle arrest.
• The bisbenzyloxy and N-(2-hydroxyethyl)formamide moieties were identified as critical pharmacophores for paraptosis induction, with bisbenzyloxy inducing ER stress and the other facilitating cytoplasmic vacuolization.

Conclusions:

• Novel anthraquinone compounds can effectively induce paraptosis, a distinct cell death pathway.
• Compound 4a represents a promising lead for developing new anticancer agents targeting cells with impaired apoptosis.
• Paraptosis offers a viable alternative therapeutic strategy for cancer chemotherapy, especially for resistant tumors.